Cost effectiveness of evidence-based treatment guidelines for the treatment of non-small-cell lung cancer in the community setting.

Neubauer, Marcus A; Hoverman, J Russell; Kolodziej, Michael; Reisman, Lonny; Gruschkus, Stephen K; Hoang, Susan; Alva, Albert A; McArthur, Marilyn; Forsyth, Michael; Rothermel, Todd; Beveridge, Roy A

Neubauer, Marcus A; Hoverman, J Russell; Kolodziej, Michael; Reisman, Lonny; Gruschkus, Stephen K; Hoang, Susan; Alva, Albert A; McArthur, Marilyn; Forsyth, Michael; Rothermel, Todd; Beveridge, Roy A.

Afiliação

Neubauer MA; Kansas City Cancer Center, Overland Park, KS; Texas Oncology, Austin; US Oncology, Houston, TX; New York Oncology Hematology, Albany, NY; Aetna Informatics; and Aetna, Hartford, CT.

J Oncol Pract ; 6(1): 12-8, 2010 Jan.

Article em En | MEDLINE | ID: mdl-20539725

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Tipo de estudo: Guideline / Health_economic_evaluation Aspecto: Patient_preference Idioma: En Revista: J Oncol Pract Ano de publicação: 2010 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google